Document:

EXHIBIT 10.83

AMENDMENT

TO THE

THIRD AMENDED AND RESTATED 

EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN

STAR SCIENTIFIC,
INC. AND 

PAUL L. PERITO

 

This Amendment (“Amendment”)
to that certain Third Amended and Restated Executive Employment Agreement between Star Scientific, Inc.,
a Delaware corporation (the “Company”) and Paul L. Perito (“Executive”) dated as of March 14, 2011
(the “Executive Employment Agreement”) is made as of this 28th day of December, 2012 (the “Amendment Date”),
by and among the Company and the Executive. Except as set forth in this Amendment, capitalized terms
used herein but not defined herein shall have the meanings ascribed to them in the Executive Employment Agreement.

 

WITNESSETH

 

WHEREAS, the Company and the Executive desire
to amend the terms of the Executive Employment Agreement to reflect the agreement to continue Executive’s employment on a
further month-to-month basis;

 

NOW, THEREFORE, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Executive and the Company (collectively the “Parties”)
hereby agree as of the Amendment Date to the following:

 

1.             Amendments
to the Employment Agreement. Effective as of the Amendment Date, the Executive Employment Agreement is hereby amended in its
entirety as follows:

 

Section “1.8” of the Executive
Employment Agreement is amended to read as follows:

 

Term.
Unless sooner terminated as provided in Section 4 hereof, the term of this Agreement shall
commence on January 1, 2011 and shall continue through December 31, 2012 and then on a month-to-month based until either Party
notifies the other of the intent not to continue the Agreement on a month-to-month basis. Notice of an intent not to continue the
Agreement on a month-to-month basis shall be effective if provided at least (15) days prior to completion of the monthly term.

 

2.    No Other Amendment.
Except as expressly set forth in this Amendment, the Executive Employment Agreement shall remain unchanged and shall continue in
full force and effect according to its terms.

 

3.    Acknowledgement.
The Executive acknowledges and agrees that the Executive has carefully read this Amendment in its entirety fully understands and
agrees to its terms and provisions and intends and agrees that it be final and legally binding on the Executive and the Company.

 

IN WITNESS WHEREOF, the Executive has hereunto
set the Executive's hand and the Company has caused this Amendment to be executed in its name on its behalf, all as of the day
and year first above written.

 

	 	STAR SCIENTIFIC, INC.
	 	 
	 	/s/ Jonnie R. Williams
	 	By:  Jonnie R. Williams
	 	Title:  Chief Executive Officer
	 	 
	 	PAUL L. PERITO
	 	 
	 	/s/ Paul L. PeritoEXHIBIT 10.84

AMENDMENT

TO THE

EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN

STAR SCIENTIFIC,
INC. AND 

JONNIE R. WILLIAMS, SR.

 

This Amendment (“Amendment”)
to that certain Executive Employment Agreement between Star Scientific, Inc., a Delaware corporation
(the “Company”) and Jonnie R. Williams, Sr. (“Executive”) dated as of March 14, 2011 (the “Executive
Employment Agreement”) is made as of this 28th day of December, 2012 (the “Amendment Date”), by and among the
Company and the Executive. Except as set forth in this Amendment, capitalized terms used herein but
not defined herein shall have the meanings ascribed to them in the Executive Employment Agreement.

 

WITNESSETH

 

WHEREAS, the Company and the Executive desire
to amend the terms of the Executive Employment Agreement to reflect the agreement to continue Executive’s employment on a
further month-to-month basis;

 

NOW, THEREFORE, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Executive and the Company (collectively the “Parties”)
hereby agree as of the Amendment Date to the following:

 

1.            Amendments
to the Employment Agreement. Effective as of the Amendment Date, the Executive Employment Agreement is hereby amended in its
entirety as follows:

 

Section “1.7” of the Executive
Employment Agreement is amended to read as follows:

 

Term.
Unless sooner terminated as provided in Section 4 hereof, the term of this Agreement shall
commence on January 1, 2011 and shall continue through December 31, 2012 and then on a month-to-month basis until either Party
notifies the other of the intent not to continue the Agreement on a month-to-month basis. Notice of an intent not to continue the
Agreement on a month-to-month basis shall be effective if provided at least (15) days prior to completion of the monthly term.

 

2.     No Other
Amendment. Except as expressly set forth in this Amendment, the Executive Employment Agreement shall remain unchanged and shall
continue in full force and effect according to its terms.

 

3.     Acknowledgement.
The Executive acknowledges and agrees that the Executive has carefully read this Amendment in its entirety fully understands and
agrees to its terms and provisions and intends and agrees that it be final and legally binding on the Executive and the Company.

 

IN WITNESS WHEREOF, the Executive has hereunto
set the Executive's hand and the Company has caused this Amendment to be executed in its name on its behalf, all as of the day
and year first above written.

 

	 	STAR SCIENTIFIC, INC.
	 	 
	 	/s/ Paul L. Perito
	 	By:  Paul L. Perito
	 	Title:  Chairman, President & COO
	 	 
	 	JONNIE R. WILLIAMS
	 	 
	 	/s/ Jonnie R. WilliamsEXHIBIT 10.12

 

ENZON PHARMACEUTICALS, INC.

2011 Outside Director Compensation Plan

 

 

Annual Retainers:

 

On an annual basis, outside directors will receive:

 

		·	a cash retainer of $50,000;

 

		·	an additional cash retainer of $18,000 for service as chair of the
Audit and Finance Committee:

 

		·	an additional cash retainer of $8,000 for service as chair of any
other committee of the board;

 

		·	an additional cash retainer of $8,000 for service as a member of the
Audit and Finance Committee; and

 

		·	an additional cash retainer of $4,000 for service as a member of any
other committee of the board.

 

The cash elements above are to be paid quarterly at the end
of each quarter, beginning with the second quarter of calendar 2011.

  

Meeting Fees:

 

For each meeting attended, outside directors will receive:

 

		·	a meeting attendance fee of $1,000 cash for each meeting of a committee
attended, either in-person or by telephone.

 

Annual Equity Grants:

 

On an annual basis, outside directors will receive:

 

		·	a grant of stock options on the first trading day of the calendar
year with a value of $25,000 (the “Annual Option Grant”). The number of options in the Annual Option Grant will be
based on a Black-Scholes value and will be at an exercise price equal to the closing price of our Common Stock on the Nasdaq Global
Market on the date of the grant. The Annual option Grant vests in one tranche on the first anniversary of the date of the grant
if the recipient director remains on our board on that date. Once vested, options granted pursuant to the Annual Option Grant expire
on the 10th anniversary of the date of the grant: and

    	 

    	 

    

 

		·	a grant of restricted stock units on the first trading day after June
30 of each calendar year with a value of $75,000 (the “Annual Restricted Stock Grant”). The number of shares issued
in the Annual Restricted Stock Grant will be equal to $75,000 divided by the closing price of our Common Stock on the Nasdaq Global
Market on the date of the grant. The shares covered by the Annual Restricted Stock Grant vest in the three equal tranches on each
of the first three anniversaries of the date of the grant if the recipient director remains on our board on each such date.

 

These grants are made under the 2001 Incentive
Stock Plan and any subsequent plan approved by the shareholders.

 

Welcome Grant:

 

		·	Upon being initially elected to the board, a new elected director
will receive a “welcome grant” of stock options with a Black-Scholes value of $25,000 (the exercise price of which
will be equal to the closing price of our Common Stock on the Nasdaq Global Market on the date of the grant) and a grant of restricted
stock units with a value of $100,000 (the number of shares covered by such grant being equal to $100,000 divided by the closing
price of our Common Stock on the Nasdaq Global Market on the date of the grant). The options and restricted stock units included
in the Welcome Grant vest in three equal tranches on each of the first three anniversaries of the date of grant, if the recipient
director remains on the Board on each such date.

 

Non-Executive Chairperson:

 

		·	If the Chairperson of the Board is a non-executive of the Company,
such Non-Executive Chairperson of the Board receives double the Annual Equity Grants, as well as double the amounts in the “Welcome
Grant”.

 

Directors’ Stock Ownership Program

 

		·	The 2007 directors’ stock ownership program requires each of
the outside directors to own shares of Common Stock with a market value of five times their annual board retainer, within five
years after the director first joins the Board. For the purposes of these guidelines the following will be counted in determining
stock ownership; 1) shares purchased on the open market, 2) shares owned jointly with or separately by spouse and/or children,
3) shares obtained through stock option exercise, 4) restricted stock or restricted stock units, and 5) vested and “in the
money” unexercised options, provided that these shares may not exceed 50% of the requirement total.EXHIBIT 10.13

 

ENZON PHARMACEUTICALS, INC.

2013 Outside Director Compensation Plan

 

 

Annual Retainers:

 

On an annual basis, outside directors will receive:

 

		·	a cash retainer of $30,000;

 

		·	an additional cash retainer of $18,000 for service as chair of the
Audit and Finance Committee:

 

		·	an additional cash retainer of $8,000 for service as chair of any
other committee of the board;

 

		·	an additional cash retainer of $8,000 for service as a member of the
Audit and Finance Committee; and

 

		·	an additional cash retainer of $4,000 for service as a member of any
other committee of the board.

 

The cash elements above are to be paid quarterly at the end
of each quarter, beginning with the first quarter of calendar 2013.

 

Annual Equity Grants:

 

On an annual basis, outside directors will receive:

 

		·	a grant of stock options on the first trading day of the calendar
year with a value of $25,000 (the “Annual Option Grant”). The number of options in the Annual Option Grant will be
based on a Black-Scholes value and will be at an exercise price equal to the closing price of our Common Stock on the Nasdaq Global
Market on the date of the grant. The Annual option Grant vests in one tranche on the first anniversary of the date of the grant
if the recipient director remains on our board on that date. Once vested, options granted pursuant to the Annual Option Grant expire
on the 10th anniversary of the date of the grant: and

    	 

    	 

    

 

 

		·	a grant of restricted stock units on the first trading day after June
30 of each calendar year with a value of $50,000 (the “Annual Restricted Stock Grant”). The number of shares issued
in the Annual Restricted Stock Grant will be equal to $50,000 divided by the closing price of our Common Stock on the Nasdaq Global
Market on the date of the grant. The shares covered by the Annual Restricted Stock Grant vest in the three equal tranches on each
of the first three anniversaries of the date of the grant if the recipient director remains on our board on each such date.

 

These grants are made under the 2001 Incentive
Stock Plan and any subsequent plan approved by the shareholders.

 

Welcome Grant:

 

		·	Upon being initially elected to the board, a new elected director
will receive a “welcome grant” of stock options with a Black-Scholes value of $25,000 (the exercise price of which
will be equal to the closing price of our Common Stock on the Nasdaq Global Market on the date of the grant) and a grant of restricted
stock units with a value of $50,000 (the number of shares covered by such grant being equal to $50,000 divided by the closing price
of our Common Stock on the Nasdaq Global Market on the date of the grant). The options and restricted stock units included in the
Welcome Grant vest in three equal tranches on each of the first three anniversaries of the date of grant, if the recipient director
remains on the Board on each such date.

 

Non-Executive Chairperson & Non-Executive Vice-Chairperson:

 

		·	If the Chairperson of the Board is a non-executive of the Company,
such Non-Executive Chairperson of the Board receives double the Annual Equity Grants, as well as double the amounts in the “Welcome
Grant”.

		·	If the Vice-Chairperson is a non-executive of the Company, such Non-Executive
Chairperson of the Board receives 1.75 times the Annual Equity Grants, as well as 1.75 times the amounts in the “Welcome
Grant.”

 

Directors’ Stock Ownership Program

 

		·	The 2007 directors’ stock ownership program requires each of
the outside directors to own shares of Common Stock with a market value of five times their annual board retainer, within five
years after the director first joins the Board. For the purposes of these guidelines the following will be counted in determining
stock ownership; 1) shares purchased on the open market, 2) shares owned jointly with or separately by spouse and/or children,
3) shares obtained through stock option exercise, 4) restricted stock or restricted stock units, and 5) vested and “in the
money” unexercised options, provided that these shares may not exceed 50% of the requirement total.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]